Cargando…

Cell Adhesive Character of Phenylboronic Acid-Modified Insulin and Its Potential as Long-Acting Insulin

Phenylboronic acid (PBA) derivatives have attracted substantial attention owing to their unique character of forming dynamic covalent bonds with polyol compounds. Recent studies have shown interactions between PBA and sugar chains on the cell surface; they have interesting applications for sensors a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohno, Yui, Kawakami, Momoko, Seki, Tomohiro, Miki, Ryotaro, Seki, Toshinobu, Egawa, Yuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789584/ https://www.ncbi.nlm.nih.gov/pubmed/31430994 http://dx.doi.org/10.3390/ph12030121

Ejemplares similares

Sugar-Responsive Pseudopolyrotaxane Composed of Phenylboronic Acid-Modified Polyethylene Glycol and γ-Cyclodextrin
por: Seki, Tomohiro, et al.
Publicado: (2015)

Investigation of factors that cause insulin precipitation and/or amyloid formation in insulin formulations
por: Ohno, Yui, et al.
Publicado: (2019)

Colorimetric Sugar Sensing Using Boronic Acid-Substituted Azobenzenes
por: Egawa, Yuya, et al.
Publicado: (2014)

Synthesis and Characterization of Phenylboronic Acid-Modified Insulin With Glucose-Dependent Solubility
por: Lin, Nai-Pin, et al.
Publicado: (2022)

Association of Cardiovascular Outcomes and Mortality With Sustained Long-Acting Insulin Only vs Long-Acting Plus Short-Acting Insulin Treatment
por: Schroeder, Emily B., et al.
Publicado: (2021)

Oxygen transfer reaction of haloalkyl amides catalyzed by phenylboronic acid
por: Sen, Abhijit, et al.
Publicado: (2023)

Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early
por: Kinney, Justin, et al.
Publicado: (2021)

Molecular Characterisation of Long-Acting Insulin Analogues in Comparison with Human Insulin, IGF-1 and Insulin X10
por: Hansen, Bo F., et al.
Publicado: (2012)

Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin
por: Jonassen, Ib, et al.
Publicado: (2012)

Effects of Ultra-Long-Acting Insulin Compared to Long-Acting Insulin on Diabetic Ketoacidosis Incidence in Type 1 Diabetes Mellitus Patients
por: Alsofiani, Wafa A, et al.
Publicado: (2022)

Determination of the Influence of Various Factors on the Character of Surface Functionalization of Copper(I) and Copper(II) Oxide Nanosensors with Phenylboronic Acid Derivatives
por: Proniewicz, Edyta, et al.
Publicado: (2021)

Selective Insulin Resistance in the Kidney
por: Horita, Shoko, et al.
Publicado: (2016)

Long-acting insulin allergy in a diabetic child
por: Mastrorilli, Carla, et al.
Publicado: (2017)

Persistent Hypoglycemia Induced by Long-acting Insulin Degludec
por: Katakura, Yukino, et al.
Publicado: (2021)

Publisher Correction: Oxygen transfer reaction of haloalkyl amides catalyzed by phenylboronic acid
por: Sen, Abhijit, et al.
Publicado: (2023)

Relationship between anti-insulin antibody production and severe insulin resistance in a diabetic cat
por: KOMIYA, Takumi, et al.
Publicado: (2021)

Phenylboronic ester-modified anionic micelles for ROS-stimuli response in HeLa cell
por: Wang, Qi Y., et al.
Publicado: (2020)

Carbon Dots Embedded Hybrid Microgel with Phenylboronic Acid as Monomer for Fluorescent Glucose Sensing and Glucose-Triggered Insulin Release at Physiological pH
por: Zhu, Jinhua, et al.
Publicado: (2022)

Massive Levemir (Long-Acting) Insulin Overdose: Case Report
por: Oduru, Mamatha, et al.
Publicado: (2012)

Budget Impact of Long-Acting Insulin Analogues: The Case in Brazil
por: Laranjeira, Fernanda O, et al.
Publicado: (2016)

Dietary Leucine - An Environmental Modifier of Insulin Resistance Acting on Multiple Levels of Metabolism
por: Macotela, Yazmin, et al.
Publicado: (2011)

A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1
por: Czech, Torrey Y., et al.
Publicado: (2018)

Treatment of Type 1 and Type 2 Diabetes Mellitus with Insulin Detemir, a Long-Acting Insulin Analog
por: Young, Jason R., et al.
Publicado: (2010)

In search of the ideal basal insulin: Does the new‐generation ultra‐long‐acting insulin, degludec, provide the answer?
por: Hui, Elaine, et al.
Publicado: (2013)

Cardiovascular safety of long‐acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?
por: Chang, Chia‐Hsuin, et al.
Publicado: (2017)

Structure-Based Design and Synthesis of a New Phenylboronic-Modified Affinity Medium for Metalloprotease Purification
por: Li, Shangyong, et al.
Publicado: (2016)

Synthesis of Water-Dispersed Ferrecene/Phenylboronic Acid-Modified Bifunctional Gold Nanoparticles and the Application in Biosensing
por: Xing, Yun, et al.
Publicado: (2014)

Enhanced Antimould Action of Surface Modified Copper Oxide Nanoparticles with Phenylboronic Acid Surface Functionality
por: Henry, Patricia, et al.
Publicado: (2021)

Insulin Degludec: A Significant Advancement in Ultralong-Acting Basal Insulin
por: Kalra, Sanjay
Publicado: (2013)

Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin
por: Evans, Marc, et al.
Publicado: (2019)

Peripheral Aβ acts as a negative modulator of insulin secretion
por: Shigemori, Keiko, et al.
Publicado: (2022)

Insulin Resistance, Obesity, Hypertension, and Renal Sodium Transport
por: Horita, Shoko, et al.
Publicado: (2011)

A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes
por: Yang, Chun-Ting, et al.
Publicado: (2021)

An ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in cats
por: Gilor, Chen, et al.
Publicado: (2021)

Ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in dogs
por: Hulsebosch, Sean E., et al.
Publicado: (2022)

Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine
por: Birkeland, Kåre I., et al.
Publicado: (2011)

A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study
por: Gordon, J, et al.
Publicado: (2010)

Treatment intensification using long-acting insulin –predictors of future basal insulin supported oral therapy in the DIVE registry
por: Danne, Thomas, et al.
Publicado: (2015)

Serum Insulin‐like Growth Factors, Insulin‐like Growth Factor‐binding Protein‐3, and Risk of Lung Cancer Death: A Case‐control Study Nested in the Japan Collaborative Cohort (JACC) Study
por: Wakai, Kenji, et al.
Publicado: (2002)

Use of fast‐acting insulin aspart in insulin pump therapy in clinical practice
por: Evans, Mark, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ouaeicn7k18oqb7j0sd55f3ejc